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Developing vaccination strategies for Rift Valley fever
in East Africa 
o Rift Valley fever is a viral disease that affects both humans and livestock (Figure 1). It is associated with
severe febrile illness in people and extensive loss of productivity in livestock. The disease is endemic in
East Africa (Figure 2).
o Livestock vaccination is the most effective way of controlling the disease in both livestock and
humans.
o ILRI conducts research on Rift Valley fever vaccines and vaccination in collaboration with the
departments of veterinary services across East Africa, Wellcome Trust, The Pirbright Institute,
Oxford University and other international institutions with an aim to produce:
• More efficacious and safe vaccines.
• Vaccination strategies which decision makers can use to guide vaccination programs.
• Guidelines on how to involve the private sector in the delivery of these vaccines.
• Knowledge on intra-household decision making processes regarding uptake of vaccines.
Initial outputs:
• Prototype adenovirus-vectored vaccine for multiple livestock species and humans
which is due for field validation
• Decision support tools that have been used to target interventions during high risk and
outbreak periods
Figure 2. Risk map for Rift Valley fever in East Africa 
This document is licensed for use under the Creative Commons Attribution 4.0 International Licence. August 2018
ILRI thanks all donors and organizations which globally support its work through their contributions to the CGIAR Trust Fund
Figure 1. Schematic representation of transmission cycles  
of the Rift Valley fever virus
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